ICL Q2 FY26 net income rises 47% to $137 million; sales climb 17% to $2.14 billion
Reuters2026/08/05 06:10- ICL posts 2Q 2026 sales of USD 2.1 billion, up 17% year-over-year; operating income climbs to USD 266 million.
- Net income attributable to shareholders rises to USD 137 million; diluted EPS increases to USD 0.11.
- Adjusted EBITDA (non-GAAP) grows to USD 448 million, up nearly USD 100 million; adjusted operating income rises to USD 281 million.
- Industrial Products sales jump to USD 414 million on higher bromine prices; segment EBITDA more than doubles to USD 130 million.
- Targets 2026 adjusted EBITDA (non-GAAP) of USD 1.5 billion-USD 1.7 billion; plans 2027 reorganization, launches “Elevate” cost program targeting over USD 350 million annualized savings by end-2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OPEC+ agrees to keep oil output policy unchanged for October
US military strikes Iranian oil tanker, triggering geopolitical risks as Brent crude nears $97 mark
Following the US military's attack on Iranian oil tankers and Iran's announcement of new restricted navigation zones outside the Strait of Hormuz, market concerns over prolonged disruptions in key energy transport routes have intensified, leading to a sharp rise in international oil prices.
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
IX Biopharma seeks SGX-ST trading halt lift for shares in Singapore
Crypto prices
More
